Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,941 | 13 | 41.1% |
| Honoraria | $11,097 | 12 | 30.5% |
| Food and Beverage | $5,718 | 306 | 15.7% |
| Travel and Lodging | $2,319 | 12 | 6.4% |
| Consulting Fee | $2,310 | 2 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $14,621 | 38 | $0 (2024) |
| ABBVIE INC. | $14,434 | 47 | $0 (2024) |
| Acorda Therapeutics, Inc | $2,400 | 7 | $0 (2024) |
| UCB, Inc. | $421.02 | 27 | $0 (2024) |
| Medtronic USA, Inc. | $355.68 | 8 | $0 (2018) |
| PFIZER INC. | $340.33 | 14 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $322.82 | 20 | $0 (2024) |
| Abbott Laboratories | $296.43 | 15 | $0 (2021) |
| US WorldMeds, LLC | $285.37 | 18 | $0 (2019) |
| Medtronic, Inc. | $250.67 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,940 | 64 | Amneal Pharmaceuticals LLC ($2,585) |
| 2023 | $1,497 | 41 | Amneal Pharmaceuticals LLC ($820.78) |
| 2022 | $3,288 | 13 | Amneal Pharmaceuticals LLC ($3,210) |
| 2021 | $5,503 | 24 | Amneal Pharmaceuticals LLC ($5,187) |
| 2020 | $6,509 | 32 | Amneal Pharmaceuticals LLC ($2,806) |
| 2019 | $6,658 | 79 | AbbVie, Inc. ($5,465) |
| 2018 | $8,351 | 51 | AbbVie, Inc. ($7,460) |
| 2017 | $638.27 | 41 | Lundbeck LLC ($97.54) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/14/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $198.65 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug), Xeomin, AMPYRA | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Parkinson's Disease | ||||||
| 10/28/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: PAIN | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Neurology | ||||||
| 10/07/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Genetic Disease | ||||||
| 09/25/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: PAIN | ||||||
| 09/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Neuropsychiatry | ||||||
| 08/28/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.37 | General |
| 08/27/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Neurology | ||||||
| 08/26/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Neurology | ||||||
| 08/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,172 | 28,723 | $1.4M | $269,156 |
| 2022 | 13 | 900 | 25,652 | $1.3M | $251,098 |
| 2021 | 16 | 992 | 22,888 | $1.2M | $249,221 |
| 2020 | 17 | 1,136 | 21,271 | $1.3M | $242,701 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 48 | 26,744 | $675,548 | $131,819 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 409 | $211,547 | $39,260 | 18.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 117 | 213 | $103,254 | $21,071 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 173 | 282 | $103,022 | $19,132 | 18.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 83 | 83 | $74,429 | $13,840 | 18.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 25 | 56 | $33,558 | $9,046 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 55 | $29,300 | $5,926 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 43 | $31,108 | $5,792 | 18.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 31 | $21,893 | $4,488 | 20.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 15 | 31 | $21,143 | $3,949 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 27 | 27 | $14,733 | $3,020 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 31 | 36 | $14,250 | $2,921 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 23 | $13,357 | $2,739 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $12,837 | $2,444 | 19.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 25 | $8,057 | $1,652 | 20.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 248 | 377 | $7,374 | $1,492 | 20.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $2,139 | $548.10 | 25.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 231 | $115.50 | $17.82 | 15.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 41 | 24,285 | $600,811 | $117,900 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 177 | 354 | $186,364 | $34,596 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 200 | 361 | $137,281 | $24,384 | 17.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 111 | 217 | $92,555 | $18,431 | 19.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 92 | 92 | $85,446 | $15,889 | 18.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 42 | $31,819 | $6,343 | 19.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 20 | 45 | $28,231 | $6,040 | 21.4% |
About Dr. Sameea Husain Wilson, D.O
Dr. Sameea Husain Wilson, D.O is a Neurology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518160852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameea Husain Wilson, D.O has received a total of $36,385 in payments from pharmaceutical and medical device companies, with $3,940 received in 2024. These payments were reported across 345 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,941).
As a Medicare-enrolled provider, Husain Wilson has provided services to 4,200 Medicare beneficiaries, totaling 98,534 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Boca Raton, FL
- Active Since 06/06/2007
- Last Updated 11/02/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518160852
Products in Payments
- RYTARY (Drug) $13,884
- Duopa (Drug) $12,925
- INBRIJA (Drug) $2,399
- DUOPA (Drug) $1,090
- ACTIVA (Device) $338.38
- NUPLAZID (Drug) $322.82
- BOTOX (Biological) $317.99
- NURTEC ODT (Drug) $294.01
- Neupro (Drug) $269.12
- Aimovig (Biological) $237.17
- LINQ II (Device) $198.65
- OCREVUS (Biological) $191.18
- Proclaim Family of SCS IPGs (Device) $171.63
- APOKYN (Drug) $169.99
- Mavenclad (Biological) $165.08
- INGREZZA (Drug) $149.49
- UBRELVY (Drug) $142.00
- AJOVY (Drug) $135.93
- Briviact (Drug) $119.90
- MYOBLOC (Biological) $91.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boca Raton
Dr. Stuart Isaacson, Md, MD
Neurology — Payments: $4.9M
Brian Steingo, Md, MD
Neurology — Payments: $1.4M
Dr. Brian Costell, M.d, M.D
Neurology — Payments: $638,608
Dr. Patricio Espinosa, Md,Mph, MD,MPH
Neurology — Payments: $215,050
Dr. Richard Isaacson, M.d, M.D
Neurology — Payments: $140,056
Gediminas Gliebus, M.d, M.D
Neurology — Payments: $120,507